Verdence Capital Advisors’s NuVasive, Inc. NUVA Stock Holding History

Verdence Capital Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,783	Closed	-$210K	–	560
2022 Q3	$210K	Buy	4,783 +210	+5%	+$10.2K	0.03%	479
2022 Q2	$225K	Buy	4,573 +974	+27%	+$52.2K	0.03%	460
2022 Q1	$204K	Buy	+3,599	New	+$191K	0.02%	494
2021 Q3	–	Sell	-2,997	Closed	-$203K	–	529
2021 Q2	$203K	Sell	2,997 -1,106	-27%	-$75.5K	0.03%	462
2021 Q1	$269K	Buy	4,103 +263	+7%	+$15.8K	0.05%	377
2020 Q4	$216K	Buy	+3,840	New	+$189K	0.04%	373

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verdence Capital Advisors's NUVA Position: Q4 2022 in Review

Verdence Capital Advisors sold out of NuVasive, Inc. (NUVA) in Q4 2022, closing a stake of 4,783 shares — an estimated $210K sold.

Verdence Capital Advisors first reported a position in NUVA in Q4 2020 and held it in 6 quarters. The position peaked at $269K in Q1 2021. 235 funds tracked by Wall St. Rank hold NUVA as of Q4 2022.

Verdence Capital Advisors reported no remaining NuVasive, Inc. position as of Q4 2022 after selling out during the quarter.
Verdence Capital Advisors sold 4,783 NuVasive, Inc. shares in Q4 2022, an estimated $210K.
Verdence Capital Advisors first reported a position in NuVasive, Inc. in Q4 2020 and held it in 6 quarters.
Verdence Capital Advisors's NuVasive, Inc. position peaked at $269K in Q1 2021.
235 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2022.

Based on Verdence Capital Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.